Global Peripheral Blood Mononuclear Cells (PBMC) Market Size, Status and Forecast 2021-2027
Table of Contents1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Peripheral Blood Mononuclear Cells (PBMC) Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 ? 50 Million Cells
1.2.3 Other
1.3 Market by Application
1.3.1 Global Peripheral Blood Mononuclear Cells (PBMC) Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 ELISPOT
1.3.3 Proliferation Assays
1.3.4 Immunogenicity Assays
1.3.5 Other
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Peripheral Blood Mononuclear Cells (PBMC) Market Perspective (2016-2027)
2.2 Peripheral Blood Mononuclear Cells (PBMC) Growth Trends by Regions
2.2.1 Peripheral Blood Mononuclear Cells (PBMC) Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Peripheral Blood Mononuclear Cells (PBMC) Historic Market Share by Regions (2016-2021)
2.2.3 Peripheral Blood Mononuclear Cells (PBMC) Forecasted Market Size by Regions (2022-2027)
2.3 Peripheral Blood Mononuclear Cells (PBMC) Industry Dynamic
2.3.1 Peripheral Blood Mononuclear Cells (PBMC) Market Trends
2.3.2 Peripheral Blood Mononuclear Cells (PBMC) Market Drivers
2.3.3 Peripheral Blood Mononuclear Cells (PBMC) Market Challenges
2.3.4 Peripheral Blood Mononuclear Cells (PBMC) Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Peripheral Blood Mononuclear Cells (PBMC) Players by Revenue
3.1.1 Global Top Peripheral Blood Mononuclear Cells (PBMC) Players by Revenue (2016-2021)
3.1.2 Global Peripheral Blood Mononuclear Cells (PBMC) Revenue Market Share by Players (2016-2021)
3.2 Global Peripheral Blood Mononuclear Cells (PBMC) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Peripheral Blood Mononuclear Cells (PBMC) Revenue
3.4 Global Peripheral Blood Mononuclear Cells (PBMC) Market Concentration Ratio
3.4.1 Global Peripheral Blood Mononuclear Cells (PBMC) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Peripheral Blood Mononuclear Cells (PBMC) Revenue in 2020
3.5 Peripheral Blood Mononuclear Cells (PBMC) Key Players Head office and Area Served
3.6 Key Players Peripheral Blood Mononuclear Cells (PBMC) Product Solution and Service
3.7 Date of Enter into Peripheral Blood Mononuclear Cells (PBMC) Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Peripheral Blood Mononuclear Cells (PBMC) Breakdown Data by Type
4.1 Global Peripheral Blood Mononuclear Cells (PBMC) Historic Market Size by Type (2016-2021)
4.2 Global Peripheral Blood Mononuclear Cells (PBMC) Forecasted Market Size by Type (2022-2027)
5 Peripheral Blood Mononuclear Cells (PBMC) Breakdown Data by Application
5.1 Global Peripheral Blood Mononuclear Cells (PBMC) Historic Market Size by Application (2016-2021)
5.2 Global Peripheral Blood Mononuclear Cells (PBMC) Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Peripheral Blood Mononuclear Cells (PBMC) Market Size (2016-2027)
6.2 North America Peripheral Blood Mononuclear Cells (PBMC) Market Size by Type
6.2.1 North America Peripheral Blood Mononuclear Cells (PBMC) Market Size by Type (2016-2021)
6.2.2 North America Peripheral Blood Mononuclear Cells (PBMC) Market Size by Type (2022-2027)
6.2.3 North America Peripheral Blood Mononuclear Cells (PBMC) Market Size by Type (2016-2027)
6.3 North America Peripheral Blood Mononuclear Cells (PBMC) Market Size by Application
6.3.1 North America Peripheral Blood Mononuclear Cells (PBMC) Market Size by Application (2016-2021)
6.3.2 North America Peripheral Blood Mononuclear Cells (PBMC) Market Size by Application (2022-2027)
6.3.3 North America Peripheral Blood Mononuclear Cells (PBMC) Market Size by Application (2016-2027)
6.4 North America Peripheral Blood Mononuclear Cells (PBMC) Market Size by Country
6.4.1 North America Peripheral Blood Mononuclear Cells (PBMC) Market Size by Country (2016-2021)
6.4.2 North America Peripheral Blood Mononuclear Cells (PBMC) Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Peripheral Blood Mononuclear Cells (PBMC) Market Size (2016-2027)
7.2 Europe Peripheral Blood Mononuclear Cells (PBMC) Market Size by Type
7.2.1 Europe Peripheral Blood Mononuclear Cells (PBMC) Market Size by Type (2016-2021)
7.2.2 Europe Peripheral Blood Mononuclear Cells (PBMC) Market Size by Type (2022-2027)
7.2.3 Europe Peripheral Blood Mononuclear Cells (PBMC) Market Size by Type (2016-2027)
7.3 Europe Peripheral Blood Mononuclear Cells (PBMC) Market Size by Application
7.3.1 Europe Peripheral Blood Mononuclear Cells (PBMC) Market Size by Application (2016-2021)
7.3.2 Europe Peripheral Blood Mononuclear Cells (PBMC) Market Size by Application (2022-2027)
7.3.3 Europe Peripheral Blood Mononuclear Cells (PBMC) Market Size by Application (2016-2027)
7.4 Europe Peripheral Blood Mononuclear Cells (PBMC) Market Size by Country
7.4.1 Europe Peripheral Blood Mononuclear Cells (PBMC) Market Size by Country (2016-2021)
7.4.2 Europe Peripheral Blood Mononuclear Cells (PBMC) Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Peripheral Blood Mononuclear Cells (PBMC) Market Size (2016-2027)
8.2 Asia-Pacific Peripheral Blood Mononuclear Cells (PBMC) Market Size by Type
8.2.1 Asia-Pacific Peripheral Blood Mononuclear Cells (PBMC) Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Peripheral Blood Mononuclear Cells (PBMC) Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Peripheral Blood Mononuclear Cells (PBMC) Market Size by Type (2016-2027)
8.3 Asia-Pacific Peripheral Blood Mononuclear Cells (PBMC) Market Size by Application
8.3.1 Asia-Pacific Peripheral Blood Mononuclear Cells (PBMC) Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Peripheral Blood Mononuclear Cells (PBMC) Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Peripheral Blood Mononuclear Cells (PBMC) Market Size by Application (2016-2027)
8.4 Asia-Pacific Peripheral Blood Mononuclear Cells (PBMC) Market Size by Region
8.4.1 Asia-Pacific Peripheral Blood Mononuclear Cells (PBMC) Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Peripheral Blood Mononuclear Cells (PBMC) Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Peripheral Blood Mononuclear Cells (PBMC) Market Size (2016-2027)
9.2 Latin America Peripheral Blood Mononuclear Cells (PBMC) Market Size by Type
9.2.1 Latin America Peripheral Blood Mononuclear Cells (PBMC) Market Size by Type (2016-2021)
9.2.2 Latin America Peripheral Blood Mononuclear Cells (PBMC) Market Size by Type (2022-2027)
9.2.3 Latin America Peripheral Blood Mononuclear Cells (PBMC) Market Size by Type (2016-2027)
9.3 Latin America Peripheral Blood Mononuclear Cells (PBMC) Market Size by Application
9.3.1 Latin America Peripheral Blood Mononuclear Cells (PBMC) Market Size by Application (2016-2021)
9.3.2 Latin America Peripheral Blood Mononuclear Cells (PBMC) Market Size by Application (2022-2027)
9.3.3 Latin America Peripheral Blood Mononuclear Cells (PBMC) Market Size by Application (2016-2027)
9.4 Latin America Peripheral Blood Mononuclear Cells (PBMC) Market Size by Country
9.4.1 Latin America Peripheral Blood Mononuclear Cells (PBMC) Market Size by Country (2016-2021)
9.4.2 Latin America Peripheral Blood Mononuclear Cells (PBMC) Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Peripheral Blood Mononuclear Cells (PBMC) Market Size (2016-2027)
10.2 Middle East & Africa Peripheral Blood Mononuclear Cells (PBMC) Market Size by Type
10.2.1 Middle East & Africa Peripheral Blood Mononuclear Cells (PBMC) Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Peripheral Blood Mononuclear Cells (PBMC) Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Peripheral Blood Mononuclear Cells (PBMC) Market Size by Type (2016-2027)
10.3 Middle East & Africa Peripheral Blood Mononuclear Cells (PBMC) Market Size by Application
10.3.1 Middle East & Africa Peripheral Blood Mononuclear Cells (PBMC) Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Peripheral Blood Mononuclear Cells (PBMC) Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Peripheral Blood Mononuclear Cells (PBMC) Market Size by Application (2016-2027)
10.4 Middle East & Africa Peripheral Blood Mononuclear Cells (PBMC) Market Size by Country
10.4.1 Middle East & Africa Peripheral Blood Mononuclear Cells (PBMC) Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Peripheral Blood Mononuclear Cells (PBMC) Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Lonza
11.1.1 Lonza Company Details
11.1.2 Lonza Business Overview
11.1.3 Lonza Peripheral Blood Mononuclear Cells (PBMC) Introduction
11.1.4 Lonza Revenue in Peripheral Blood Mononuclear Cells (PBMC) Business (2016-2021)
11.1.5 Lonza Recent Development
11.2 STEMCELL Technologies
11.2.1 STEMCELL Technologies Company Details
11.2.2 STEMCELL Technologies Business Overview
11.2.3 STEMCELL Technologies Peripheral Blood Mononuclear Cells (PBMC) Introduction
11.2.4 STEMCELL Technologies Revenue in Peripheral Blood Mononuclear Cells (PBMC) Business (2016-2021)
11.2.5 STEMCELL Technologies Recent Development
11.3 Zen-Bio
11.3.1 Zen-Bio Company Details
11.3.2 Zen-Bio Business Overview
11.3.3 Zen-Bio Peripheral Blood Mononuclear Cells (PBMC) Introduction
11.3.4 Zen-Bio Revenue in Peripheral Blood Mononuclear Cells (PBMC) Business (2016-2021)
11.3.5 Zen-Bio Recent Development
11.4 ATCC
11.4.1 ATCC Company Details
11.4.2 ATCC Business Overview
11.4.3 ATCC Peripheral Blood Mononuclear Cells (PBMC) Introduction
11.4.4 ATCC Revenue in Peripheral Blood Mononuclear Cells (PBMC) Business (2016-2021)
11.4.5 ATCC Recent Development
11.5 AllCells
11.5.1 AllCells Company Details
11.5.2 AllCells Business Overview
11.5.3 AllCells Peripheral Blood Mononuclear Cells (PBMC) Introduction
11.5.4 AllCells Revenue in Peripheral Blood Mononuclear Cells (PBMC) Business (2016-2021)
11.5.5 AllCells Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesTable 1. Global Peripheral Blood Mononuclear Cells (PBMC) Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of ? 50 Million Cells
Table 3. Key Players of Other
Table 4. Global Peripheral Blood Mononuclear Cells (PBMC) Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Peripheral Blood Mononuclear Cells (PBMC) Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Peripheral Blood Mononuclear Cells (PBMC) Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Peripheral Blood Mononuclear Cells (PBMC) Market Share by Regions (2016-2021)
Table 8. Global Peripheral Blood Mononuclear Cells (PBMC) Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Peripheral Blood Mononuclear Cells (PBMC) Market Share by Regions (2022-2027)
Table 10. Peripheral Blood Mononuclear Cells (PBMC) Market Trends
Table 11. Peripheral Blood Mononuclear Cells (PBMC) Market Drivers
Table 12. Peripheral Blood Mononuclear Cells (PBMC) Market Challenges
Table 13. Peripheral Blood Mononuclear Cells (PBMC) Market Restraints
Table 14. Global Peripheral Blood Mononuclear Cells (PBMC) Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Peripheral Blood Mononuclear Cells (PBMC) Market Share by Players (2016-2021)
Table 16. Global Top Peripheral Blood Mononuclear Cells (PBMC) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Peripheral Blood Mononuclear Cells (PBMC) as of 2020)
Table 17. Ranking of Global Top Peripheral Blood Mononuclear Cells (PBMC) Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Peripheral Blood Mononuclear Cells (PBMC) Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Peripheral Blood Mononuclear Cells (PBMC) Product Solution and Service
Table 21. Date of Enter into Peripheral Blood Mononuclear Cells (PBMC) Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Peripheral Blood Mononuclear Cells (PBMC) Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Peripheral Blood Mononuclear Cells (PBMC) Revenue Market Share by Type (2016-2021)
Table 25. Global Peripheral Blood Mononuclear Cells (PBMC) Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Peripheral Blood Mononuclear Cells (PBMC) Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Peripheral Blood Mononuclear Cells (PBMC) Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Peripheral Blood Mononuclear Cells (PBMC) Revenue Market Share by Application (2016-2021)
Table 29. Global Peripheral Blood Mononuclear Cells (PBMC) Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Peripheral Blood Mononuclear Cells (PBMC) Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Peripheral Blood Mononuclear Cells (PBMC) Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Peripheral Blood Mononuclear Cells (PBMC) Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Peripheral Blood Mononuclear Cells (PBMC) Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Peripheral Blood Mononuclear Cells (PBMC) Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Peripheral Blood Mononuclear Cells (PBMC) Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Peripheral Blood Mononuclear Cells (PBMC) Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Peripheral Blood Mononuclear Cells (PBMC) Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Peripheral Blood Mononuclear Cells (PBMC) Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Peripheral Blood Mononuclear Cells (PBMC) Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Peripheral Blood Mononuclear Cells (PBMC) Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Peripheral Blood Mononuclear Cells (PBMC) Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Peripheral Blood Mononuclear Cells (PBMC) Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Peripheral Blood Mononuclear Cells (PBMC) Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Peripheral Blood Mononuclear Cells (PBMC) Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Peripheral Blood Mononuclear Cells (PBMC) Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Peripheral Blood Mononuclear Cells (PBMC) Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Peripheral Blood Mononuclear Cells (PBMC) Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Peripheral Blood Mononuclear Cells (PBMC) Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Peripheral Blood Mononuclear Cells (PBMC) Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Peripheral Blood Mononuclear Cells (PBMC) Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Peripheral Blood Mononuclear Cells (PBMC) Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Peripheral Blood Mononuclear Cells (PBMC) Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Peripheral Blood Mononuclear Cells (PBMC) Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Peripheral Blood Mononuclear Cells (PBMC) Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Peripheral Blood Mononuclear Cells (PBMC) Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Peripheral Blood Mononuclear Cells (PBMC) Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Peripheral Blood Mononuclear Cells (PBMC) Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Peripheral Blood Mononuclear Cells (PBMC) Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Peripheral Blood Mononuclear Cells (PBMC) Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Peripheral Blood Mononuclear Cells (PBMC) Market Size by Country (2022-2027) & (US$ Million)
Table 61. Lonza Company Details
Table 62. Lonza Business Overview
Table 63. Lonza Peripheral Blood Mononuclear Cells (PBMC) Product
Table 64. Lonza Revenue in Peripheral Blood Mononuclear Cells (PBMC) Business (2016-2021) & (US$ Million)
Table 65. Lonza Recent Development
Table 66. STEMCELL Technologies Company Details
Table 67. STEMCELL Technologies Business Overview
Table 68. STEMCELL Technologies Peripheral Blood Mononuclear Cells (PBMC) Product
Table 69. STEMCELL Technologies Revenue in Peripheral Blood Mononuclear Cells (PBMC) Business (2016-2021) & (US$ Million)
Table 70. STEMCELL Technologies Recent Development
Table 71. Zen-Bio Company Details
Table 72. Zen-Bio Business Overview
Table 73. Zen-Bio Peripheral Blood Mononuclear Cells (PBMC) Product
Table 74. Zen-Bio Revenue in Peripheral Blood Mononuclear Cells (PBMC) Business (2016-2021) & (US$ Million)
Table 75. Zen-Bio Recent Development
Table 76. ATCC Company Details
Table 77. ATCC Business Overview
Table 78. ATCC Peripheral Blood Mononuclear Cells (PBMC) Product
Table 79. ATCC Revenue in Peripheral Blood Mononuclear Cells (PBMC) Business (2016-2021) & (US$ Million)
Table 80. ATCC Recent Development
Table 81. AllCells Company Details
Table 82. AllCells Business Overview
Table 83. AllCells Peripheral Blood Mononuclear Cells (PBMC) Product
Table 84. AllCells Revenue in Peripheral Blood Mononuclear Cells (PBMC) Business (2016-2021) & (US$ Million)
Table 85. AllCells Recent Development
Table 86. Research Programs/Design for This Report
Table 87. Key Data Information from Secondary Sources
Table 88. Key Data Information from Primary Sources
List of FiguresFigure 1. Global Peripheral Blood Mononuclear Cells (PBMC) Market Share by Type: 2020 VS 2027
Figure 2. ? 50 Million Cells Features
Figure 3. Other Features
Figure 4. Global Peripheral Blood Mononuclear Cells (PBMC) Market Share by Application: 2020 VS 2027
Figure 5. ELISPOT Case Studies
Figure 6. Proliferation Assays Case Studies
Figure 7. Immunogenicity Assays Case Studies
Figure 8. Other Case Studies
Figure 9. Peripheral Blood Mononuclear Cells (PBMC) Report Years Considered
Figure 10. Global Peripheral Blood Mononuclear Cells (PBMC) Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global Peripheral Blood Mononuclear Cells (PBMC) Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Peripheral Blood Mononuclear Cells (PBMC) Market Share by Regions: 2020 VS 2027
Figure 13. Global Peripheral Blood Mononuclear Cells (PBMC) Market Share by Regions (2022-2027)
Figure 14. Global Peripheral Blood Mononuclear Cells (PBMC) Market Share by Players in 2020
Figure 15. Global Top Peripheral Blood Mononuclear Cells (PBMC) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Peripheral Blood Mononuclear Cells (PBMC) as of 2020
Figure 16. The Top 10 and 5 Players Market Share by Peripheral Blood Mononuclear Cells (PBMC) Revenue in 2020
Figure 17. Global Peripheral Blood Mononuclear Cells (PBMC) Revenue Market Share by Type (2016-2021)
Figure 18. Global Peripheral Blood Mononuclear Cells (PBMC) Revenue Market Share by Type (2022-2027)
Figure 19. North America Peripheral Blood Mononuclear Cells (PBMC) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America Peripheral Blood Mononuclear Cells (PBMC) Market Share by Type (2016-2027)
Figure 21. North America Peripheral Blood Mononuclear Cells (PBMC) Market Share by Application (2016-2027)
Figure 22. North America Peripheral Blood Mononuclear Cells (PBMC) Market Share by Country (2016-2027)
Figure 23. United States Peripheral Blood Mononuclear Cells (PBMC) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada Peripheral Blood Mononuclear Cells (PBMC) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Peripheral Blood Mononuclear Cells (PBMC) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Peripheral Blood Mononuclear Cells (PBMC) Market Share by Type (2016-2027)
Figure 27. Europe Peripheral Blood Mononuclear Cells (PBMC) Market Share by Application (2016-2027)
Figure 28. Europe Peripheral Blood Mononuclear Cells (PBMC) Market Share by Country (2016-2027)
Figure 29. Germany Peripheral Blood Mononuclear Cells (PBMC) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France Peripheral Blood Mononuclear Cells (PBMC) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. Peripheral Blood Mononuclear Cells (PBMC) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy Peripheral Blood Mononuclear Cells (PBMC) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia Peripheral Blood Mononuclear Cells (PBMC) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic Peripheral Blood Mononuclear Cells (PBMC) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Peripheral Blood Mononuclear Cells (PBMC) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Peripheral Blood Mononuclear Cells (PBMC) Market Share by Type (2016-2027)
Figure 37. Asia-Pacific Peripheral Blood Mononuclear Cells (PBMC) Market Share by Application (2016-2027)
Figure 38. Asia-Pacific Peripheral Blood Mononuclear Cells (PBMC) Market Share by Region (2016-2027)
Figure 39. China Peripheral Blood Mononuclear Cells (PBMC) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan Peripheral Blood Mononuclear Cells (PBMC) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea Peripheral Blood Mononuclear Cells (PBMC) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia Peripheral Blood Mononuclear Cells (PBMC) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India Peripheral Blood Mononuclear Cells (PBMC) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia Peripheral Blood Mononuclear Cells (PBMC) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Peripheral Blood Mononuclear Cells (PBMC) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Peripheral Blood Mononuclear Cells (PBMC) Market Share by Type (2016-2027)
Figure 47. Latin America Peripheral Blood Mononuclear Cells (PBMC) Market Share by Application (2016-2027)
Figure 48. Latin America Peripheral Blood Mononuclear Cells (PBMC) Market Share by Country (2016-2027)
Figure 49. Mexico Peripheral Blood Mononuclear Cells (PBMC) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil Peripheral Blood Mononuclear Cells (PBMC) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Peripheral Blood Mononuclear Cells (PBMC) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Peripheral Blood Mononuclear Cells (PBMC) Market Share by Type (2016-2027)
Figure 53. Middle East & Africa Peripheral Blood Mononuclear Cells (PBMC) Market Share by Application (2016-2027)
Figure 54. Middle East & Africa Peripheral Blood Mononuclear Cells (PBMC) Market Share by Country (2016-2027)
Figure 55. Turkey Peripheral Blood Mononuclear Cells (PBMC) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia Peripheral Blood Mononuclear Cells (PBMC) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE Peripheral Blood Mononuclear Cells (PBMC) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Lonza Revenue Growth Rate in Peripheral Blood Mononuclear Cells (PBMC) Business (2016-2021)
Figure 59. STEMCELL Technologies Revenue Growth Rate in Peripheral Blood Mononuclear Cells (PBMC) Business (2016-2021)
Figure 60. Zen-Bio Revenue Growth Rate in Peripheral Blood Mononuclear Cells (PBMC) Business (2016-2021)
Figure 61. ATCC Revenue Growth Rate in Peripheral Blood Mononuclear Cells (PBMC) Business (2016-2021)
Figure 62. AllCells Revenue Growth Rate in Peripheral Blood Mononuclear Cells (PBMC) Business (2016-2021)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed